Wider use of Pre-Exposure Prophylaxis (PrEP), where people who don't have HIV take a pill every day, could prevent around 7,400 new HIV infections in the UK by 2020.
In the first of his two-part article Chris Jennings identifies the false assumptions in HIV / AIDS incidence estimates that may have lead to a gross overestimation of the disease. The situation with the African HIV/AIDS epidemic is analogous to that of the global finance crisis. Thousands of diligent people are...
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.